T. Rowe Price Associates’s CEL-SCI Corp CVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-893
Closed -$29K 3023
2024
Q3
$29K Hold
893
﹤0.01% 2972
2024
Q2
$32K Hold
893
﹤0.01% 2893
2024
Q1
$52K Hold
893
﹤0.01% 2868
2023
Q4
$73K Hold
893
﹤0.01% 2761
2023
Q3
$34K Hold
893
﹤0.01% 2821
2023
Q2
$65K Hold
893
﹤0.01% 2771
2023
Q1
$63K Hold
893
﹤0.01% 2757
2022
Q4
$63K Hold
893
﹤0.01% 2785
2022
Q3
$83K Buy
893
+233
+35% +$28.1K ﹤0.01% 2763
2022
Q2
$89K Buy
660
+127
+24% +$13.2K ﹤0.01% 2778
2022
Q1
$63K Buy
+533
New +$86.8K ﹤0.01% 2901
2021
Q4
Sell
-706
Closed -$233K 2994
2021
Q3
$233K Sell
706
-350
-33% -$102K ﹤0.01% 2668
2021
Q2
$275K Sell
1,056
-14
-1% -$8.66K ﹤0.01% 2619
2021
Q1
$488K Buy
1,070
+78
+8% +$42.6K ﹤0.01% 2380
2020
Q4
$347K Buy
992
+483
+95% +$191K ﹤0.01% 2376
2020
Q3
$195K Buy
509
+153
+43% +$60.3K ﹤0.01% 2425
2020
Q2
$159K Sell
356
-126
-26% -$51.7K ﹤0.01% 2381
2020
Q1
$167K Buy
+482
New +$176K ﹤0.01% 2349

Other funds holding CVM

T. Rowe Price Associates's CVM Position: Q4 2024 in Review

T. Rowe Price Associates sold out of CEL-SCI Corp (CVM) in Q4 2024, closing a stake of 893 shares — an estimated $29K sold.

T. Rowe Price Associates first reported a position in CVM in Q1 2020 and held it in 18 quarters. The position peaked at $488K in Q1 2021. 60 funds tracked by Wall St. Rank hold CVM as of Q4 2024.

  • T. Rowe Price Associates reported no remaining CEL-SCI Corp position as of Q4 2024 after selling out during the quarter.
  • T. Rowe Price Associates sold 893 CEL-SCI Corp shares in Q4 2024, an estimated $29K.
  • T. Rowe Price Associates first reported a position in CEL-SCI Corp in Q1 2020 and held it in 18 quarters.
  • T. Rowe Price Associates's CEL-SCI Corp position peaked at $488K in Q1 2021.
  • 60 funds tracked by Wall St. Rank held CEL-SCI Corp as of Q4 2024.

Based on T. Rowe Price Associates's 13F filing for Q4 2024, filed 14 Feb 2025.